*Shigella* species are the causative agent of an inflammatory diarrhea called bacillary dysentery or shigellosis. *Shigella dysenteriae* serotype 1 is the only one of the 4 *Shigella* species that has been recognized as producing Shiga toxins (Stx), which are potent cytotoxins that produce hemorrhagic colitis that can lead to the serious hemolytic uremic syndrome (HUS) \[[@OFV134C1]\]. In *S dysenteriae* 1, the genes encoding *stx* are found on the *S dysenteriae* 1 chromosome in an operon consisting of *stxA* and *stxB* and are flanked by DNA sequence homologous to lambdoid bacteriophages; however, the toxin genes are not associated with a complete prophage genome \[[@OFV134C2], [@OFV134C3]\]. In contrast, in Stx-producing *Escherichia coli* (STEC), *stx* is commonly carried by intact lambdoid prophages, which allow for horizontal spread of the toxin genes \[[@OFV134C4]\].

In recent studies, *stx*-encoding prophages have been identified in non-*S dysenteriae* 1 *Shigella* species \[[@OFV134C5]--[@OFV134C7]\]. In 2 previous reports, we characterized a new *stx*-encoding phage, φPOC-J13, in *Shigella* isolated from travelers returning to the United States and France from Haiti or the Dominican Republic \[[@OFV134C8], [@OFV134C9]\]. Those findings suggested that emergence of *stx*-positive *Shigella* is linked to that region. In this study, we confirmed that Stx-producing Shigella are circulating in Haiti: stools from Haitian patients were screened for Shigella and the presence of stx and the stx-encoding lambdoid phage. In addition, we demonstrate that φPOC-J13 is capable of lysogenizing *stx*-negative *Shigella* species isolated from Haitian patients, indicating that this *stx*-encoding bacteriophage has the ability to infect other *Shigella* strains circulating within Haiti.

METHODS {#s2}
=======

Isolation of Clinical Samples and Growth Conditions {#s2a}
---------------------------------------------------

*Shigella* species were isolated from stools as described by Livio et al \[[@OFV134C10]\]. After isolation, *Shigella* strains were grown in Tryptic Soy Broth (TSB) (BD Difco, Franklin Lakes, NJ) at 37°C with aeration or on TSB plates containing 1.5% agar (TSB agar) with or without 0.025% Congo red (Sigma-Aldrich, St. Louis, MO). *Escherichia coli* K-12 strain MG1655 was grown in Luria-Bertani (LB) broth and on LB agar plates.

Polymerase Chain Reaction Analysis of *Shigella* Clinical Isolates {#s2b}
------------------------------------------------------------------

Cell lysates were used for polymerase chain reaction (PCR) to detect *stx* with primers stx1-det-F1 and stx1-seq-R1 \[[@OFV134C9]\]. The *stx*-encoding isolates were analyzed by PCR to show that *stx* was phage encoded using primers Stx1R2/Phage_stxR2 and Phage_stx1F2/Stx1F2 \[[@OFV134C9]\]. The insertion site of the phage into locus S1742 or a homologous gene was determined by PCR using primers to the region upstream of S1742 and an early phage gene (primers S1742_up/Stx_phage_up) and by amplifying a late phage gene and the region downstream of S1742 with primers S1742_dn/Stx_phage_dn \[[@OFV134C9]\].

Toxin and Phage Production {#s2c}
--------------------------

Production and release of Stx was measured using bacterial lysates and supernatants in a Vero cell cytotoxicity assay as previously described \[[@OFV134C9]\]. Production of viable phage progeny was determined in a plaque-forming assay by absorbing overnight supernatants from the *stx*-encoding isolates onto *E coli* MG1655 as previously described \[[@OFV134C9]\].

Construction of φPOC-J13Δ*stx* {#s2d}
------------------------------

The *stx* operon in φPOC-J13 was replaced with a kanamycin resistance cassette using lambda red recombination in a laboratory strain of *Shigella flexneri*, 2457T, lysogenized with φPOC-J13 and transformed with pKM208 \[[@OFV134C11]\]. Primers Stxko-site1 (5-aaaataattatttttagagtgctaacttttttctttgttatcttttcagttgtgtaggctggagctgcttc-3) and Stxko-site2 (5-acgaaaaataacttcgctgaatccccctccattatgacaggcattagttttcatatgaatatcctcctta-3) were used to amplify *kan* from pKD4 with 5′ and 3′ overhangs homologous to internal regions of the *stx* operon. Kanamycin-resistant recombinants were double purified and screened by PCR with primers Stxup (5-ccgtaaaacgccgtccttca-3) and Stxdn (5-catttatgaatctccgcctgc-3). A P1L4 lysate was grown on this mutant and used to transduce the *stx*::*kan* mutation into BS937, an *S flexneri* clinical isolate harboring φPOC-J13 \[[@OFV134C9]\], to create strain BS1076. Kanamycin-resistant transductants were purified and confirmed by PCR as described above.

Lysogeny of *stx*-Negative *Shigella* Isolates {#s2e}
----------------------------------------------

Supernatants from overnight cultures of BS1076 were absorbed with log phase cultures of the *stx*-negative isolates in a 1:2 ratio for 20 minutes at 37°C as described previously \[[@OFV134C9], [@OFV134C12]\]. After incubation, 10 mM sodium acetate was added to stop phage absorption. Isolates were allowed to grow in 2 mL TSB for 90 minutes at 37°C before being plated on TSB agar-Congo red plates containing 50 µg/mL kanamycin. Kanamycin-resistant colonies were twice colony purified and confirmed to be φPOC-J13Δ*stx* lysogens using primers Stxup and Stxdn. BS1058 (Table [1](#OFV134TB1){ref-type="table"}) was lysogenized with wild-type φPOC-J13 using the soft agar spotting method previously described \[[@OFV134C9]\]. Two independently isolated lysogens of each strain were used for further analysis. Table 1.Clinical Isolates of *Shigella* From Haitian Patients Characterized in This StudyStrainSpecies*stx*-PositiveClinic SiteIsolation DateAgeGenderGenBank Accession No.BS1039*Shigella flexneri* 2aYesChristianville School, Gressier21 November 201216FLAJQ00000000BS1057*S flexneri* 2aYesNotre-Dame Hospital, Petit Goâve17 December 201310MLAJS00000000BS1059*S flexneri* 2aYesNotre-Dame Hospital, Petit Goâve26 March 20146FLAJU00000000BS1060*S flexneri* YYesNotre-Dame Hospital, Petit Goâve1 April 201420MLAJV00000000BS1038*S flexneri* 3aNoSaint Croix Hospital, Léogâne2 July 20136MLAJP00000000BS1061*S flexneri* 3aNoNotre-Dame Hospital, Petit Goâve7 April 201470MLAJW00000000BS1040*S flexneri* 6NoChristianville School, Gressier21 November 20129MLAJR00000000BS1058*Shigella sonnei*NoGeorge Guavan Hospital, Grand Goâve23 January 201447MLAJT00000000

Determination of Antibiotic Resistance {#s2f}
--------------------------------------

Isolates were grown overnight on Tryptic Soy Agar at 37°C. Isolated colonies were processed for antibiotic resistance profiles using the Sensititre Antimicrobial Sensitivity Testing assay according to manufacturer\'s instructions (Sensititre, Thermo Scientific, Waltham, MA).

Whole-Genome Sequencing and Analysis {#s2g}
------------------------------------

Genomic DNA was extracted from overnight cultures using the DNeasy Blood and Tissue Kit (QIAGEN, Germantown, MD). Sequencing libraries were prepared with either the TruSeq DNA Sample Prep Kit (Illumina, San Diego, CA) or the Nextera DNA Sample Prep Kit (Illumina) and sequenced on the Illumina MiSeq Platform, generating paired-end 250 base-pair reads in sufficient quantity to provide \>49× coverage for each genome. Raw reads were trimmed, and draft genome sequences were assembled de novo with CLC Genomics Workbench version 7.0.3 or 7.0.4 (CLC bio, Boston, MA). In strains carrying the *stx* gene, the entire *stx-*encoding phage was contained on 1 contig. The *stx*-encoding prophage sequences were extracted from the genomic assemblies of the strains investigated and aligned to the phage φPOC-J13 reference sequence (GenBank accession no. KJ603229) using the SeqMan Pro module of the Lasergene software package (DNASTAR Inc., Madison, WI).

Nucleotide Sequence Accession Numbers {#s2h}
-------------------------------------

Whole draft genome sequences have been deposited at DDBJ/EMBL/GenBank under the accession numbers listed in Table [1](#OFV134TB1){ref-type="table"}.

RESULTS {#s3}
=======

Fourteen *Shigella* isolates were obtained between 2012 and 2014 from patients at 5 different clinics located west of Port-au-Prince in the Ouest Department (Figure [1](#OFV134F1){ref-type="fig"}). Serological analysis determined that the isolates consisted of 7 *S flexneri* and 7 *Shigella sonnei* strains. This classification was confirmed by whole-genome sequencing. Four of the *S flexneri* isolates were positive for *stx* by PCR, whereas all of the *S sonnei* isolates were negative. Although the majority of the patients presented with diarrhea characterized as unremarkable, 2 of the patients had bloody and mucoid stools. One of those patients had been infected with a *stx*-positive *S flexneri* 2a (BS1059; Table [1](#OFV134TB1){ref-type="table"}), whereas the other patient was infected with a *stx*-negative *S flexneri* 6 (BS1040). In addition, none of the patients were reported to have developed HUS as a complication of infection. Figure 1.Location of clinics in Haiti where *Shigella* was isolated from patients. Map created in Google custom maps; Map Data\@2015 Google.

All 7 *S flexneri* isolates and 1 of the *S sonnei* strains were further characterized, and epidemiological data for these strains are listed in Table [1](#OFV134TB1){ref-type="table"}. The 4 *stx*-positive *S flexneri* isolates (BS1039, BS1057, BS1059, and BS1060) produced and released Stx as shown in a Vero cell cytotoxicity assay. None of the *stx*-negative bacterial lysates (BS1038, BS1040, BS1058, and BS1061) produced any proteins that were cytotoxic to Vero cells. We also determined that the 4 Stx-producing isolates produced viable prophage by a plaque-forming unit assay on the *E coli* indicator strain MG1655.

To test whether the phage observed was a *stx*-encoding phage, we performed PCR using primers based on the φPOC-J13 sequence to demonstrate that the *stx* operon was flanked by sequence homologous to φPOC-J13. In our previous studies, we found that φPOC-J13 is inserted into the *S flexneri* chromosome at locus S1742. Polymerase chain reaction analysis using the primers from those studies demonstrated that the phage in the Stx-producing Haiti isolates was also inserted into S1742 or a homologous gene. Whole-genome sequencing of the isolates confirmed that the *stx* genes were encoded by a bacteriophage. The *stx*-encoding prophage sequences from the 4 strains were aligned and compared with phage φPOC-J13. The 5 prophages were nearly identical in sequence with only 3 single nucleotide polymorphisms among them.

Bacteriophages are powerful agents of bacterial evolution due to their ability to mediate horizontal transfer of genes. When phages such as φPOC-J13 infect a susceptible bacterium, they can enter a lysogenic state whereby the phage DNA inserts into the bacterial chromosome and replicates along with it. In this lysogenic state, the bacterium can express genes from the integrated phage and display new properties \[[@OFV134C4]\]. Therefore, we wanted to determine whether the *stx*-negative *Shigella* isolates could be lysogenized with φPOC-J13. We used φPOC-J13Δ*stx*, a mutant of φPOC-J13 where the *stx* operon has been replaced with a kanamycin-resistant cassette, and screened for kanamycin resistance as described under Methods. All 4 of the *stx*-negative *Shigella* isolates yielded kanamycin-resistant colonies following phage infection. Two isolates of each were confirmed by PCR to be lysogenized with φPOC-J13Δ*stx*. Polymerase chain reaction also determined that φPOC-J13Δ*stx* had inserted into S1742 or a homologous gene in BS1038, BS1058, and BS1061. It is interesting to note that the BS1040 φPOC-J13Δ*stx* lysogens did not produce a positive PCR product for insertion into S1742. Analysis of the sequence from the assembled BS1040 genome indicated that it did not encode S1742 or the adjacent genes, suggesting that the phage inserted into a different locus in BS1040.

Because none of the 7 *S sonnei* isolates from Haitian patients were *stx* positive, we wanted to investigate whether the *S sonnei* isolate (BS1058) could be stably lysogenized with wild-type φPOC-J13 and produce toxin. Two colonies of BS1058 lysogenized with φPOC-J13 were isolated and confirmed by PCR analysis to contain the *stx* genes flanked by phage sequence, as well as insertion into S1742. The 2 BS1058 φPOC-J13 lysogens also produced and released toxin in a Vero cell cytotoxicity assay.

Lastly, because of the increasing emergence of antibiotic resistance in clinical isolates of *Shigella*, we wanted to determine the antibiotic resistance profiles of all 8 of the isolates characterized. Overall, the antibiotic resistance profiles were unremarkable. The 7 *S flexneri* isolates were resistant to tetracyline and chloramphenicol, and only the *S sonnei* isolate (BS1058) showed sensitivity. All 8 of the isolates were sensitive to ciprofloxacin.

DISCUSSION {#s4}
==========

Our previous reports identifying Stx-producing *Shigella* species in international travelers led to the hypothesis that emergence of these strains is related to travel to Haiti and the Dominican Republic. This study reinforces that hypothesis by confirming the presence of *stx*-encoding *Shigella* in stool samples from Haitian patients. Although there were a low number of isolates over the study period, approximately 29% of *Shigella* isolated between 2012 and 2014 from the 5 clinical sites were *stx* positive. Moreover, all of the *stx*-encoding *Shigella* species identified harbored a phage identical to φPOC-J13. This suggests that φPOC-J13 is responsible for the horizontal spread of *stx* genes to diverse *Shigella* serogroups and serotypes in Haiti.

Although the majority of *stx*-positive *Shigella* isolates carrying φPOC-J13 that we have characterized are *S flexneri* 2a \[[@OFV134C8], [@OFV134C9]\], clinical isolates of *S flexneri* Y and *S dysenteriae* 4 harboring φPOC-J13 have been reported \[[@OFV134C8]\]. In addition, we have identified φPOC-J13 as the carrier of the *stx* genes from a previous report \[[@OFV134C6]\] of 4 isolates of *stx*-encoding *S dysenteriae* 4 associated with travel to Hispaniola (our unpublished data) as well as *Shigella boydii* 19 isolates from travelers returning to the United States from that region (our unpublished data). Although the limited species range identified for φPOC-J13 thus far suggests that the phage is specific to certain *Shigella* serogroups and serotypes, in this study we were able to lysogenize *stx*-negative clinical isolates of *S flexneri* 3a, *S flexneri* 6, and *S sonnei* from Haitian patients with φPOC-J13. This finding demonstrates that the host range of φPOC-J13 is more extensive than previously recognized. It is possible that as φPOC-J13 spreads to additional *Shigella* species, Stx-producing *Shigella* may become more prevalent in Haiti.

An outbreak of ciprofloxacin-resistant *S sonnei* that recently occurred in the United States was associated with international travel, including patients who had traveled to the Dominican Republic or Haiti \[[@OFV134C13]\]. Although none of the isolates characterized in our study were ciprofloxacin-resistant, the association of these Stx-producing *Shigella* species with international travel \[[@OFV134C8], [@OFV134C9]\] highlight their potential for global spread. More importantly, because ciprofloxacin is the current recommendation for treatment of *Shigella* infections for persons 18 years of age and older, the emergence of these *stx*-producing strains of *Shigella* should raise some alarms. Treatment of STEC infections with ciprofloxacin may have significant adverse clinical consequences because it can induce the lysogenic lambdoid phage that encodes the toxin and increase toxin production \[[@OFV134C14]\]. We have shown that φPOC-J13 can also be induced by treatment with ciprofloxacin with concomitant increase in Stx production (our unpublished data). Given the concerns noted above with ciprofloxacin resistance, combined with the risk that ciprofloxacin-sensitive strains may be carrying Stx (raising the possibility of phage and toxin induction with ciprofloxacin therapy), it may be wise to limit empiric use of ciprofloxacin in *Shigella*-infected patients who have a recent history of travel to Hispaniola.

CONCLUSIONS {#s5}
===========

Infection with bacteria that produce Stx can lead to more serious disease including the development of HUS, as found in approximately 10% of cases \[[@OFV134C15]\]. Although none of the isolates we have identified so far resulted in HUS, the potential exists for these species to cause more severe disease. The prevalence of Stx-producing *Shigella* should continue to be monitored to better understand the extent of the emergence in Hispaniola, the spread to foreign travelers, and the clinical consequences of infection with Stx-producing *Shigella*.
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